Company news

Novamind Inc news in 2022

Novamind Inc's news releases, calls and decks from 2022, newest first.

View company

CSE Bulletin: Delist -Novamind Inc. (NM)

June 13, 2022

Novamind Obtains Final Order for Plan of Arrangement from the Supreme Court of British Columbia and Completes Acquisition by Numinus Wellness Inc.

June 10, 2022

Novamind Shareholders Approve Proposed Acquisition by Numinus

June 8, 2022

Novamind Announces New Patient Financing Options

June 2, 2022

Novamind Reports Fiscal Q3 2022 Financial Results and Operating Highlights

May 31, 2022

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders of Novamind Vote FOR the Proposed Plan of Arrangement

May 27, 2022

Novamind Launches Group Psychedelic Treatment for Frontline Workers

May 19, 2022

Novamind Files Management Information Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement

May 11, 2022

Novamind to Host Bionomics' PREVAIL Trial for Acute Treatment of Social Anxiety Disorder

May 10, 2022

Novamind Announces Virtual Group Health Coaching

May 2, 2022

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

April 12, 2022

Novamind Opens 8th Integrative Psychiatry Clinic

April 6, 2022

Novamind Partner to Acquire Specialized Ibogaine Group in Brazil

March 31, 2022

Novamind Expands Group Therapy Model

March 24, 2022

Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety

March 16, 2022

Novamind Grants Restricted Share Units

March 11, 2022

Novamind to Conduct Phase II Psilocybin Trial for Major Depressive Disorder

March 9, 2022

Novamind Reports Fiscal Q2 2022 Financial Results and Operating Highlights

March 1, 2022

Novamind Publishes Psychedelic Therapy Patient Case Studies

February 22, 2022

Novamind Advances Clinical Pilot for Frontline KAP

February 16, 2022

Novamind Participates in Alto Neuroscience Phase II Clinical Trial for MDD and PTSD

February 9, 2022

Novamind Appoints Prakash Gowd as Chief Operating Officer

February 8, 2022

Novamind Hosts Clinical Trial to Advance Ketamine Therapy for End-of-Life Patients

February 3, 2022

Novamind Announces Closing of CAD$5 Million Private Placement with Institutional Investor

January 25, 2022

Novamind Announces CAD$5 Million Private Placement with Institutional Investor

January 24, 2022

Novamind to Participate in Citi's Psychedelic Drug Video Call Series

January 20, 2022

Novamind Closes Arizona Acquisition

January 18, 2022

Novamind Hosts Pioneering Psychedelic Clinical Trial for Opioid Use Disorder

January 13, 2022

Novamind Unveils New Design Concept for Clinics

January 5, 2022